Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccinationEspen B. Ellingsen, Gustav Gaudernack, Donjetë Simnica et al.|Journal of Translational Medicine|2022Cited by 21
382 The synthetic long peptide cancer vaccine UV1 in combination with ipilimumab induces a CD4+ Th1 anti-hTERT immune response and an inflammatory tumor microenvironment in patients with melanomaEspen B. Ellingsen, Gustav Gaudernack, Iliana Kerzeli et al.|Regular and Young Investigator Award Abstracts|2021Cited by 0